• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA PLUS VASCULAR COVERED STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG COVERA PLUS VASCULAR COVERED STENT SYSTEM Back to Search Results
Catalog Number AASME10060
Device Problem Obstruction of Flow (2423)
Patient Problem Stenosis (2263)
Event Date 02/12/2020
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.The catalog number identified has not been cleared in the u.S.But, it is similar to the covera plus vascular covered stent products that are cleared in the us.The 510 k number and pro code for the covera plus vascular covered stent products are identified.(expiry date: 12/2021).
 
Event Description
It was reported that approximately three months post stent graft implantation in the left common iliac artery, the vessel allegedly experienced restenosis.The patient is currently oligosymptomatic.
 
Event Description
It was reported that approximately three months post stent graft implantation in the left common iliac artery, the vessel allegedly experienced restenosis.The patient is currently oligosymptomatic.
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the u.S.But, it is similar to the covera plus vascular covered stent products that are cleared in the us.The 510 k number and pro code for the covera plus vascular covered stent products are identified in d2 and g5.Manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the stent remains implanted.Therefore, no product is available for evaluation.Based on the report of the physician a duplex sonography was performed to diagnose a recurrent stenosis in the left arteria iliaca communis, the target vessel of the initial stent placement.There is no reference to an x-ray examination.Therefore no x-ray images are available to verify the integrity of the stent.Based on the information available the investigation is closed with inconclusive result.A definite root cause for the reported event could not be determined.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H10: d4 (expiry date: 12/2021).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COVERA PLUS VASCULAR COVERED STENT SYSTEM
Type of Device
VASCULAR COVERED STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key9814917
MDR Text Key187056147
Report Number9681442-2020-00062
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741136023
UDI-Public(01)00801741136023
Combination Product (y/n)N
PMA/PMN Number
P170042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberAASME10060
Device Lot NumberANDV1995
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/13/2020
Initial Date FDA Received03/10/2020
Supplement Dates Manufacturer Received08/11/2020
Supplement Dates FDA Received08/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
APIRIN; APIRIN; ATORVASTATIN; ATORVASTATIN; CLOPIDOGREL; CLOPIDOGREL; HEPARIN; HEPARIN
Patient Outcome(s) Other;
Patient Age59 YR
Patient Weight70
-
-